---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-025767"
form_type: "8-K"
ticker: "SFES"
cik: "0000086115"
company_name: "SAFEGUARD SCIENTIFICS INC"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:47:28.621421+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Safeguard Scientifics Q3 2022 net loss $3.2M vs prior-year net income $18.3M

## Summary
- Received $5.3M initial cash proceeds from Lumesis acquisition, recording a gain of $4.7M.
- Funded $1.6M convertible note in Syapse's $35M growth capital round; capital to expand real-world insights for cancer.
- Trailing 12-month revenues for eight portfolio companies were $139M, up 10.7% YoY.
- Repurchased 84,261 shares in Q3 at avg $4.00; YTD repurchases 453,535 shares for $2.1M.
- Operating costs reduced: G&A expenses $1.4M vs $1.6M in prior-year quarter.

## SEC filing metadata
- accession: 0001437749-22-025767
- form_type: 8-K
- ticker: SFES
- cik: 0000086115
- company_name: SAFEGUARD SCIENTIFICS INC
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/86115/000143774922025767/0001437749-22-025767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/86115/000143774922025767/sfe20221102_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-025767
- JSON: https://secwatch.observer/filing/0001437749-22-025767.json
- Plain text: https://secwatch.observer/filing/0001437749-22-025767.txt

## Key facts
- Earnings Releases
  SAFEGUARD SCIENTIFICS INC reported three and nine months ended September 30, 2022 results: net income Net loss for the three months ended September 30, 2022 was $3.2 million, or $0.19 per share, compared with a net income.
  - Period: three and nine months ended September 30, 2022
  - Net income: Net loss for the three months ended September 30, 2022 was $3.2 million, or $0.19 per share, compared with a net income
  - Result: reported results
  source text: o Net loss for the three months ended September 30, 2022 was $3.2 million, or $0.19 per share, compared with a net income of $18.3 million, or $0.88 per share, for the same period in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/86115/000143774922025767/0001437749-22-025767-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.